Practical recommendations for the management of diabetes in patients with COVID-19

By Stefan R Bornstein, Francesco Rubino, Kamlesh Khunti, G. Mingrone, D. Hopkins, A. L. Birkenfeld, Bernhard O. Boehm, S. Amiel, R. I. Holt, Jay S. Skyler and 10 more. The Lancet Diabetes and Endocrinology, 2020

794 citations recorded by the source corpus.

Diabetes is one of the most important comorbidities linked to the severity of all three known human pathogenic coronavirus infections, including severe acute respiratory syndrome coronavirus 2. Patients with diabetes have an increased risk of severe complications including Adult Respiratory Distress Syndrome and multi-organ failure. Depending on the global region, 20–50% of patients in the coronavirus disease 2019 (COVID-19) pandemic had diabetes. Given the importance of the link between COVID-19 and diabetes, we have formed an international panel of experts in the field of diabetes and endocrinology to provide some guidance and practical recommendations for the management of diabetes during the pandemic. We aim to briefly provide insight into potential mechanistic links between the novel coronavirus infection and diabetes, present practical management recommendations, and elaborate on the differential needs of several patient groups.

Subfields: Endocrinology, Diabetes and Metabolism, Genetics, Infectious Diseases

View Paper: https://www.semanticscholar.org/paper/cf8939936a914deff7400130a75b7703208359ad

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

  1. Lihua Zhu
  2. Zhi‐Gang She
  3. Xu Cheng
  4. Ming-Ming Chen
  5. You-qin Yan
  6. Xiaohui Song
  7. Jingjing Cai
  8. Wenxin Wang

Citations in the corpus